Indication: It is suitable for preventing rejection reactions of allogeneic kidney, liver, heart, bone marrow and other organs or tissues transplanted, and is also suitable for preventing and treating graft-versus-host reactions during bone marrow transplantation. This product is often used in combination with immunosuppressants such as adrenocortical hormones to improve the efficacy. In recent years, there have been reports of trials for the treatment of uveitis, severe aplastic anemia, refractory autoimmune thrombocytopenic purpura, psoriasis, refractory lupus nephritis, etc.

Indication: 1. Confirmed indications (1) Transplantation a. Organ transplantation - prevention of allogeneic transplant rejection, including kidney, liver, heart, lung, combined heart-lung and pancreas transplantation. - Treatment of transplant rejection in patients who have received other immunosuppressants. b. Bone marrow transplantation - prevention of bone marrow transplant rejection. - Prevention and treatment of GVHD. (2) Non-transplant indications The person who diagnoses and prescribes this product should be a physician with experience in the use of immunosuppressants, especially cyclosporine. a. Endogenous uveitis - active non-infectious uveitis of the central or posterior part of the body with a risk of blindness, in which conventional therapy is ineffective or produces unacceptable adverse reactions. - Patients aged 7-70 years with Behcet's uveitis and recurrent retinitis with normal renal function. b. Psoriasis

Indication: 1. Prevent and treat rejection or graft-versus-host reaction of allogeneic organ transplantation or bone marrow transplantation. 2. Treat autoimmune diseases such as lupus nephritis and refractory nephrotic syndrome that have not been effectively treated with other immunosuppressants.

Indication: Used for 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and (or) uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.

Indication: It is used for ① primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; ② recurrent or chronic gout; ③ tophi; ④ uric acid kidney stones and (or) uric acid nephropathy; ⑤ hyperuricemia with renal insufficiency.

Indication: Used to treat various types of edema, such as edema or ascites caused by congestive heart failure, cirrhosis and nephrotic syndrome; also used to treat mild to moderate essential hypertension.

Indication: Organ transplantation, bone marrow transplantation, autoimmune diseases such as endogenous uveitis, rheumatoid arthritis, atopic dermatitis, psoriasis, etc.; nephrotic syndrome.

Indication: 1. Prevent and treat rejection or graft-versus-host reaction of allogeneic organ transplantation or bone marrow transplantation. 2. Autoimmune diseases such as lupus nephritis and refractory nephrotic syndrome that are ineffective after other immunosuppressive agents.

Indication: 1. Prevent and treat rejection or graft-versus-host reaction of allogeneic organ transplantation or bone marrow transplantation. 2. Treat autoimmune diseases such as lupus nephritis and refractory nephrotic syndrome that have not been effectively treated with other immunosuppressants.